Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9L2WN
|
|||
| Drug Name |
PEP-CMV
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1 | [1] | |
| Medulloblastoma [ICD-11: 2A00.10; ICD-10: C71.6; ICD-9: 191] | Phase 1 | [1] | ||
| Company |
Annias Immunotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03299309) PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (PRiME). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.